Table 2 COVID-19 symptoms and signs of the studied groups
From: Acute kidney injury in hospitalized patients with COVID-19 (retrospective study)
Parameter | All (n = 86) | AKI (n = 61) | Non-AKI (n = 25) | P value* |
|---|---|---|---|---|
Clinical manifestations | ||||
• Fever | 66 (76.8%) | 50 (82%) | 16 (64%) | 0.036 |
• Headache | 20 (23.3%) | 15 (24.6%) | 5 (20%) | 0.239 |
• Vomiting | 17 (19.8%) | 12 (19.7%) | 5 (20%) | 0.480 |
• Vertigo | 3 (3.5%) | 3 (4.9%) | 0 (0%) | 0.152 |
• Cough | 44 (51.2%) | 34 (55.7%) | 10 (40%) | 0.098 |
• Dyspnea | 36 (41.9%) | 24 (39.3%) | 12 (48%) | 0.308 |
• Loss of smell | 46 (43.5%) | 29 (47.5%) | 17 (68%) | 0.086 |